FACT.BO stock jumped 33.78% to INR 886.45 in pre-market trade on 12 Mar 2026, driven by heavy volume of 1,825,608.00 shares and a gap above yesterday’s close of INR 662.60. The move places The Fertilisers And Chemicals Travancore Limited (FACT Ltd) well above its 50-day average of INR 807.12 and near the intraday high of INR 928.95. Traders cite strong sector flows into Basic Materials and short-covering given the stock’s low average daily volume of 14,637.00 shares. We walk through valuation, technicals, Meyka AI grade and price forecasts that shape the pre-market top-gainer case.
Pre-market price action and drivers
FACT.BO stock opened at INR 838.15 and hit a pre-market high of INR 928.95, reflecting a +33.78% change from the previous close of INR 662.60. Volume spiked to 1,825,608.00 versus an average daily volume of 14,637.00, implying a relative volume of 36.54 and likely institutional or block activity. Market context: Basic Materials sector showed buying, but FACT’s move is significantly larger than sector peers, pointing to idiosyncratic news or repositioning ahead of upcoming catalysts.
FACT.BO stock fundamentals and valuation
On fundamentals, The Fertilisers And Chemicals Travancore Limited reports EPS INR 0.46 and a trailing PE of 1,728.48, reflecting elevated price versus reported earnings. Key ratios: PB 37.36, debt-to-equity 2.81, and current ratio 0.91. Book value per share is INR 21.27 while cash per share is INR 34.37, which highlights a stretched market valuation versus tangible equity. Market cap stands at INR 514,486,926,527.00 and investors should weigh the valuation gap against revenue per share INR 81.85 and weak profitability margins.
Technical view and trading setup for FACT.BO stock
Technically, RSI sits at 56.16 with MFI overbought at 92.52, suggesting strong buying but limited immediate upside without consolidation. Short-term supports: INR 795.50 (day low) and INR 807.12 (50-day average). Resistance: day high INR 928.95 and yearly high INR 1,111.00. Volatility indicators: ATR INR 37.61 and Bollinger upper band INR 855.08, indicating wide intraday ranges. Momentum traders may favor scaled entries near INR 820.15 or wait for pullback confirmation.
Meyka AI rates FACT.BO with a score out of 100
Meyka AI rates FACT.BO with a score of 64.91 out of 100 — Grade B, suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, industry peers, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth. The model weights include sector and industry comparisons (32%), key metrics and growth (28%), forecasts (8%), and analyst inputs (14%). These grades are informational only and are not investment advice.
Meyka AI forecast and price targets
Meyka AI’s forecast model projects a monthly level of INR 680.07, a quarterly level of INR 820.15, and a yearly target of INR 1,256.76. Compared with the current price INR 886.45, the model implies an upside to yearly target of +41.78% and a downside to the monthly projection of -23.29%. Forecasts are model-based projections and not guarantees; they reflect scenario-driven outcomes using fundamentals, technicals and alternative data.
Risks and catalysts shaping FACT.BO performance
Key catalysts: sector demand for fertilisers, caprolactam by-product margins, government policy on subsidies and any block deals or institutional filings that surface in pre-market. Risks include stretched valuation metrics (PE 1,728.48, PB 37.36), high leverage (debt-to-equity 2.81), thin average volume (14,637.00) and weak operating margins. Upcoming earnings announcement is dated 25 May 2026, which could re-rate the stock depending on reported margins and inventory dynamics.
Final Thoughts
FACT.BO stock is a clear pre-market top gainer on 12 Mar 2026, rising 33.78% to INR 886.45 on unusually high volume of 1,825,608.00 shares. The rally outpaces Basic Materials sector moves and appears driven by idiosyncratic flows. Valuation metrics remain stretched: trailing PE 1,728.48, PB 37.36, and modest return on equity 2.06%, which argue for prudence. Meyka AI’s forecast model projects a yearly price target of INR 1,256.76 (implied +41.78% upside) and a nearer-term monthly projection of INR 680.07 (implied -23.29% downside). Traders should weigh momentum against valuation risk, use stops given ATR INR 37.61, and monitor official filings or block-trade disclosures. For more real-time metrics and price alerts, see our Meyka AI-powered market analysis page for FACT.BO at https://meyka.ai/stocks/FACT.BO. Sources: latest market commentary on Investing.com and peer comparisons Investing.com report 1 and Investing.com report 2. Forecasts are model-based projections and not guarantees.
FAQs
Why did FACT.BO stock jump in pre-market on 12 Mar 2026?
FACT.BO stock rose 33.78% on heavy pre-market volume (1,825,608.00 shares). Drivers include sector flows into Basic Materials, short-covering, and possible institutional activity or news ahead of earnings. Market filings or block deals can confirm the move.
What valuation metrics should investors watch for FACT.BO stock?
Key metrics: trailing PE 1,728.48, PB 37.36, debt-to-equity 2.81, ROE 2.06%, and book value per share INR 21.27. These indicate a high price relative to earnings and equity, so monitor margins and cash flow updates.
What are Meyka AI’s near-term and yearly targets for FACT.BO stock?
Meyka AI forecasts a near-term monthly level at INR 680.07 and a yearly target of INR 1,256.76. Compared with current INR 886.45, that implies a -23.29% downside to monthly and +41.78% upside to yearly. Forecasts are projections, not guarantees.
How should traders manage risk on FACT.BO stock after the pre-market surge?
Given ATR INR 37.61 and overbought MFI 92.52, use scaled entries, tight stops and predefined profit targets. Consider waiting for pullback to support near INR 795.50–INR 820.15 or confirmation above INR 928.95 before adding exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)